CS logo
small CS logo
UPMC Late-Life Depression, Evaluation, Prevention, and Treatment Program

Pittsburgh, Pennsylvania, United States

About UPMC Late-Life Depression, Evaluation, Prevention, and Treatment Program


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at UPMC Late-Life Depression, Evaluation, Prevention, and Treatment Program


During the past decade, UPMC Late-Life Depression, Evaluation, Prevention, and Treatment Program conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Late-Life Depression, Evaluation, Prevention, and Treatment Program" #1 collaborator was "National Institute of Mental Health (NIMH)" with 2 trials as a collaborator and "Patient-Centered Outcomes Research Institute" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at UPMC Late-Life Depression, Evaluation, Prevention, and Treatment Program


According to Clinical.Site data, the most researched conditions in "UPMC Late-Life Depression, Evaluation, Prevention, and Treatment Program" are "Depression" (2 trials), "Geriatric Depression" (2 trials), "Late Life Depression" (2 trials), "Treatment Resistant Depression" (2 trials) and "Back Pain" (1 trials). Many other conditions were trialed in "UPMC Late-Life Depression, Evaluation, Prevention, and Treatment Program" in a lesser frequency.

Clinical Trials Intervention Types at UPMC Late-Life Depression, Evaluation, Prevention, and Treatment Program


Most popular intervention types in "UPMC Late-Life Depression, Evaluation, Prevention, and Treatment Program" are "Behavioral" (3 trials), "Drug" (3 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Aripiprazole Augmentation" (1 trials), "Bupropion Augmentation" (1 trials), "Clinical Scales" (1 trials), "Cognitive Behavioral Therapy for Pain CBT-P" (1 trials) and "Enhanced Treatment as Usual" (1 trials). Other intervention names were less common.

Clinical Trials Genders at UPMC Late-Life Depression, Evaluation, Prevention, and Treatment Program


The vast majority of trials in "UPMC Late-Life Depression, Evaluation, Prevention, and Treatment Program" are 5 trials for "All" genders.

Clinical Trials Status at UPMC Late-Life Depression, Evaluation, Prevention, and Treatment Program


Currently, there are NaN active trials in "UPMC Late-Life Depression, Evaluation, Prevention, and Treatment Program". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in UPMC Late-Life Depression, Evaluation, Prevention, and Treatment Program, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in UPMC Late-Life Depression, Evaluation, Prevention, and Treatment Program, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".